Boehringer Ingelheim

Lilly’s Diabetes Pill Rejected by FDA Over Manufacturing
Bloomberg
Wed, 03/5/14 - 11:44 am
FDA
Eli Lilly
diabetes
empagliflozin
Boehringer Ingelheim
Boehringer Ingelheim withheld Pradaxa data from FDA, lawsuit files show
Fierce Pharma
Wed, 02/26/14 - 11:16 am
Pradaxa
Boehringer Ingelheim
Boehringer blood thinner lawsuits due to start in August
Yahoo/Reuters
Wed, 02/19/14 - 08:39 am
Boehringer Ingelheim
bloodthinners
Pradaxa
Boehringer facing more than 2,000 U.S. lawsuits over blood thinner
Yahoo/Reuters
Thu, 02/13/14 - 09:11 am
bloodthinners
Pradaxa
Boehringer Ingelheim
Puma Biotech Surges on Favorable Patent Ruling
Yahoo/Zacks.com
Mon, 02/10/14 - 05:32 pm
Puma Biotechnology
patents
neratinib
Boehringer Ingelheim
Pradaxa files show drug marketers weighing in on how to communicate the drug's risks
Fierce Pharma
Fri, 02/7/14 - 10:50 am
Pradaxa
Boehringer Ingelheim
blood thinners
The top 10 pharma companies in social media
Fierce Pharma Marketing
Wed, 02/5/14 - 09:55 am
social media
JNJ
GSK
Novo Nordisk
UCB Pharmaceuticals
Pfizer
Boehringer Ingelheim
Novartis
Bayer
Merck
AstraZeneca
FDA returns for look at risk of Boehringer Ingelheim's Pradaxa
Fierce Pharma
Mon, 01/6/14 - 04:53 pm
Pradaxa
FDA
Boehringer Ingelheim
bloodthinners
New Trial Confirms Role For Pradaxa In Venous Thromboembolism
Forbes
Wed, 12/18/13 - 10:48 am
Venous Thrombo-Embolism
Pradaxa
bloodthinners
Boehringer Ingelheim
Boehringer's blood clot drug shows promise in broader use trial
Yahoo/Reuters
Tue, 12/17/13 - 10:58 am
Boehringer Ingelheim
Pradaxa
blood thinners
Stomach acid drugs may increase vitamin deficiency risk
Reuters
Wed, 12/11/13 - 12:11 pm
PPIs
H2RAs
Prevacid
Prilosec
Nexium
Tagamet
Zantac
GSK
Boehringer Ingelheim
P&G
AstraZeneca
Takeda
Boehringer to Pay $931,000 Fine Over Lost Pradaxa Files
Bloomberg
Tue, 12/10/13 - 09:41 am
Boehringer Ingelheim
Pradaxa
Large Study Finds Favorable Risk-Benefit Profile For The New Anticoagulants
Forbes
Thu, 12/5/13 - 06:45 pm
bloodthinners
Pradaxa
Boehringer Ingelheim
Xarelto
JNJ
Eliquis
Pfizer
Bristol-Myers Squibb
edoxaban
Daiichi Sankyo
Boehringer Ingelheim looks for a buyer for its troubled Bedford operation
Fierce Pharma
Wed, 12/4/13 - 11:45 am
drug manufacturing
Boehringer Ingelheim
Pradaxa antidote works fast, completely in small trial
Reuters
Mon, 11/18/13 - 11:48 am
bloodthinners
Pradaxa
Boehringer Ingelheim
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
patents
Copaxone
Teva
Nexium
AstraZeneca
Micardis
Boehringer Ingelheim
Sandostatin LAR
Novartis
Exforge
Nasonex
Merck
TriLipix
AbbVie
Evista
Eli Lilly
Restasis
Allergan
Renagel
Sanofi
Boehringer unit that makes Johnson & Johnson Doxil to shut, WSJ says
Yahoo/Fly on the Wall
Fri, 10/4/13 - 10:10 am
JNJ
Doxil
drug shortages
ovarian cancer
Boehringer Ingelheim
J&J Says Boehringer Doxil Dispute May Cause Shortage
Bloomberg
Wed, 10/2/13 - 10:05 am
JNJ
Boehringer Ingelheim
drug shortages
Doxil
ovarian cancer
China Biotech In Review: Amgen Partners With ShanghaiTech On China R&D Center
Seeking Alpha
Sun, 09/29/13 - 01:29 pm
Mindray
JHL Biotech
Amgen
Sinochem Jiangsu Pharma
Boehringer Ingelheim
Eli Lilly presents data from post-hoc analyses of linagliptin
Yahoo/Fly on the Wall
Tue, 09/24/13 - 10:09 am
Eli Lilly
linagliptin
Boehringer Ingelheim
diabetes

Pages